These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [Study of hypolipemic effect of atheroid in ischemic heart disease associated with various types of hyperlipoproteinemia]. Zakharov VN Sov Med; 1978 Jan; (1):147-8. PubMed ID: 76342 [No Abstract] [Full Text] [Related]
10. Reducing drug usage and adverse effects. Part III: Cardiovascular disease and hyperlipidemia. Baron M Health Care Food Nutr Focus; 2005 Jun; 22(6):7-11. PubMed ID: 15923907 [No Abstract] [Full Text] [Related]
11. [Treatment of hyperlipidemia in patients with ischemic heart disease]. Pauciullo P; Lirato C; Sapio C; Mancini M Cardiologia; 1993 Dec; 38(12 Suppl 1):345-8. PubMed ID: 8020035 [TBL] [Abstract][Full Text] [Related]
12. [Treatment of lipid metabolism disorders in the elderly]. Mizera W; Grzeszczak W Wiad Lek; 1998; 51 Suppl 2():52-7. PubMed ID: 9686534 [TBL] [Abstract][Full Text] [Related]
13. Aggressive medical therapy for the prevention and treatment of coronary artery disease. Malloy MJ; Kane JP Dis Mon; 1998 Jan; 44(1):1-40. PubMed ID: 9457050 [No Abstract] [Full Text] [Related]
14. [Hyperlipidemia, coronary disease and antilipemic drugs--do they help?]. Hansteen V Tidsskr Nor Laegeforen; 1995 Nov; 115(29):3602-3. PubMed ID: 8539711 [No Abstract] [Full Text] [Related]
15. [Treatment of hyperlipidemia in the prevention of ischemic heart disease. A proposal for the unification of medical management. I and II]. Adamska-Dyniewska H; Chojnowska-Jezierska J; Cybulska B; Dzieniszewski J; Hryniewiecki L; Idzior-Waluś B; Jabłońska-Kaszewska I; Jaszcz-Kanecka A; Kłosiewicz-Latoszek L; Kokot F Wiad Lek; 1992 May; 45(9-10):388-400. PubMed ID: 1441551 [No Abstract] [Full Text] [Related]
16. Treatment of hyperlipidaemias. Current avenues and new horizons. Janus ED Aust Fam Physician; 1989 Sep; 18(9):1071-4, 1078-83, 1086. PubMed ID: 2590074 [TBL] [Abstract][Full Text] [Related]
17. [Also elderly patients with hyperlipidemia and coronary disease need lipid lowering agents]. Hellénius ML Lakartidningen; 2001 Sep; 98(39):4188-90. PubMed ID: 11680152 [No Abstract] [Full Text] [Related]
18. Lipid disorders: applying new guidelines to your older patients. Leaf DA Geriatrics; 1994 May; 49(5):35-41. PubMed ID: 8174939 [TBL] [Abstract][Full Text] [Related]
19. [Lipiwatch: a study of the treatment of dyslipidemias in Luxembourg]. Michel G; Wirion R; Keipes M; Scharpantgen R; Heger G; Bull Soc Sci Med Grand Duche Luxemb; 2001; (1):29-36. PubMed ID: 11570211 [TBL] [Abstract][Full Text] [Related]
20. [Should lipid-lowering drugs be administered to normolipemic or mild hyperlipemic patients with coronary risk factors? Arguments for]. de Teresa Galván E; Jiménez Navarro M Rev Esp Cardiol; 1996 Jul; 49(7):483-5. PubMed ID: 8754441 [No Abstract] [Full Text] [Related] [Next] [New Search]